Dr. Kathleen M Donovan, DO Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 500 Corporate Pkwy, Suite 100, Amherst, NY 14226 Phone: 716-631-0380 Fax: 716-631-3229 |
Dr. Jeanne Marie Lomas, DO Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 500 Corporate Pkwy Ste 100, Amherst, NY 14226 Phone: 716-631-0380 Fax: 716-836-0773 |
Dr. Gulam M Najar, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 30 Amsterdam Ave, Amherst, NY 14226 Phone: 716-837-7424 Fax: 716-837-3889 |
Helen M Evrard, M.D. Allergy & Immunology - Allergy Medicare: Not Enrolled in Medicare Practice Location: 3950 E Robinson Rd, Amherst, NY 14228 Phone: 716-231-4466 Fax: 716-213-4462 |
Dr. Michael James Fanning, MD Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 500 Corporate Pkwy, Suite 100, Amherst, NY 14226 Phone: 716-631-0380 Fax: 716-631-3229 |
Dr. Madeline A Lillie, MD Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 500 Corporate Pkwy, Suite 100, Amherst, NY 14226 Phone: 716-631-0380 Fax: 716-631-3229 |
News Archive
Valor Medical's CEO, H. Clark Adams, announced today that Valor's European clinical trial was finalized with 30 patients treated. Mr. Adams stated, "The trial took longer than expected because there are current approved therapies which were used as a first line of therapy. Patients who were enrolled to be treated with Valor's Neucrylate were not always acceptable candidates for these standard-of-care therapies.
Lead continues to pose a significant public health problem in spite of substantial reductions in lead exposure in the United States in the recent past, according to background information in the article.
When a form of cancer that begins in the milk ducts of the breast invades neighboring tissue to spread to other parts of the body, the cause lies not in the tumor cells themselves but in a group of abnormal surrounding cells that cause the walls of the duct to deteriorate like a rusty pipe, according to a new study led by Dana-Farber Cancer Institute researchers.
Salk scientists have identified a unique molecular signature in induced pluripotent stem cells (iPSCs), "reprogrammed" cells that show great promise in regenerative medicine thanks to their ability to generate a range of body tissues.
› Verified 9 days ago